Illegal drugs
Alternative labels
Illegal drug crime
Illicit drugs
Position paper
Achieving a health-focused approach to drug policy in Australia and Aotearoa New Zealand
This statement provides the rationale and evidence for a health-focused approach to guide governments at all levels in Australia and Aotearoa New Zealand to develop an all-of-government, comprehensive response to illicit drug problems. It outlines an effective drug policy response including educational, preventative and harm reduction measures, evidence-based treatment services and regulatory options to reduce...
Report
Impact of the regulatory framework for cannabis in New South Wales
The committee has been informed by a substantial body of evidence that has shaped its view that law reform regarding the regulation of cannabis in New South Wales is not only urgently needed but is also the only rational course of action. This first report makes several preliminary findings and recommendations for law reform.
Report
Illicit drug policy: developments since the 2020 Ice Inquiry report
The purpose of this paper is to provide an update on key policy developments since the report of the NSW Special Commission of Inquiry into the Drug Ice in January 2020. The paper summarises the former government's response to the inquiry recommendations and notes progress that has been made since then. Significant reforms in other...
Report
The New Zealand illicit drug harm index 2023
A comprehensive evaluation of the costs (both personal and to the broader community) of illicit drug use in New Zealand, including legal drugs diverted to the illicit market and excluding alcohol and tobacco.
Report
The Australian ‘drug budget’: government drug policy expenditure 2021/22
This report provides an estimate of Australian governments’ proactive expenditure on illicit drugs for the financial year 2021/22. Four drug policy domains were included: prevention, treatment, harm reduction, and law enforcement. The report finds that Australian governments spend more on law enforcement in illicit drug policy than treatment, prevention and harm reduction combined.